Jiangxi XinGanjiang Pharmaceutical Co., Ltd. (Stock Code: 873167), founded in 2004 and listed in 2023, is a national high-tech enterprise specializing in APIs, chemical drugs, and traditional Chinese medicines. Key products include gluconates (e.g., calcium gluconate), vitamin C chewable tablets, and cold/cardiovascular medicines, with leading market shares. The company emphasizes R&D, with 22 technicians and 14 ongoing projects in fields like cardiovascular and vitamin therapies, collaborating with external partners to enhance innovation.

Its subsidiary, Justiu Pharmaceutical Co., Ltd., was restructured from Jiangxi Ji'an Pharmaceutical Factory, a large-scale state-owned enterprise of traditional Chinese medicine founded in 1958. It is a Chinese patent medicine production enterprise with a long history and profound Chinese medicine culture. The company covers an area of 30,000 square meters and is equipped with seven dosage production lines for pills, mixtures, wine preparations, decoctions, ointments, liniments, and syrups. The core products include "Ejiao Blood-Replenishing Paste", "Erbao Paste", "Wuji Baifeng Pills", etc. Its characteristic "Agkistrodon acutus  Medicinal Wine" has been rated as an intangible cultural heritage of the country and Jiangxi Province. Justiu Pharmaceutical adheres to the concept of "inheriting authentic products", strictly requires material selection, strives for excellence in production, and sincerely cooperates with customers with high-quality and effective products for joint development.